RETNLB and metabolic dysfunction-associated steatohepatitis: To investigate the molecular mechanisms underlying the resistance to NASH development of RELMβ-KO mice, we analyzed the hepatic expression levels of factors involved in lipid accumulation, inflammation and fibrotic changes.